Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06142357
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2023-11-16
Brief Title:
Secukinumab Drug Survival Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-16
First Submit QC Date:
November 16 2023
Study First Post Date:
2023-11-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-09
Last Update Post Date:
2024-04-10
Last Update Post Date Type:
ACTUAL